Experts
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Proteomics International Laboratories.
RELATED STOCKHEAD STORIES
News
Mining, Consumer Staples are the only major ASX sectors in the green this year
Experts
Scopo’s health powerplays: Clinical trials are back
News
Rise and Shine: What you need to know before the ASX opens
News
Lunchtime ASX small cap wrap: Who’s prepared for a ‘new normal (COVID-19 edition)’ today?
Health & Biotech
Health & Biotech: Mesoblast still not in the black, but they’re less in the red than last year
News
Rise and Shine: What you need to know before the ASX opens
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Health: Orthocell believes CelGro can help repair ACL injuries
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Biotech: Mesoblast scores $US150m stem cell partnership to treat back pain, shares jump
Health & Biotech
Health: Cann Group gets the next tick of approval for its medicinal cannabis operations
Health & Biotech
Health: Elixinol pivots to pet pot treats, nabs 25pc stake in US hemp manufacturer
News
Rise and Shine: What you need to know before the ASX opens
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
US big pharma company Janssen to use Proteomics’ kidney test
Health & Biotech
Check up: here’s what’s happening with 140 ASX small cap health stocks
News
